|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
|
CA2435146C
(en)
|
2001-01-25 |
2011-03-29 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Formulation of boronic acid compounds
|
|
US7576206B2
(en)
|
2003-08-14 |
2009-08-18 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
US7232818B2
(en)
|
2004-04-15 |
2007-06-19 |
Proteolix, Inc. |
Compounds for enzyme inhibition
|
|
ATE494298T1
(de)
|
2004-04-15 |
2011-01-15 |
Proteolix Inc |
Verbindungen zur proteasomenzymhemmung
|
|
EP2261236B1
(en)
|
2004-12-07 |
2015-07-15 |
Onyx Therapeutics, Inc. |
Composition for proteasome inhibition
|
|
EP2623113B1
(en)
|
2005-11-09 |
2017-05-31 |
Onyx Therapeutics, Inc. |
Compound for enzyme inhibition
|
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
SI2318419T2
(sl)
|
2008-06-17 |
2025-10-30 |
Takeda Pharmaceutical Company Limited |
Spojine boronat estra in njihovi farmacevtski sestavki
|
|
AR075899A1
(es)
|
2009-03-20 |
2011-05-04 |
Onyx Therapeutics Inc |
Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
|
|
WO2011060179A1
(en)
|
2009-11-13 |
2011-05-19 |
Onyx Therapeutics, Inc |
Use of peptide epoxyketones for metastasis suppression
|
|
EP2714737A1
(en)
|
2011-05-27 |
2014-04-09 |
Glaxo Group Limited |
Bcma (cd269/tnfrsf17) -binding proteins
|
|
UA112434C2
(uk)
*
|
2011-05-27 |
2016-09-12 |
Ґлаксо Ґруп Лімітед |
Антигензв'язувальний білок, який специфічно зв'язується з всма
|
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
|
MX353603B
(es)
|
2012-02-28 |
2018-01-19 |
Cydex Pharmaceuticals Inc |
Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas.
|
|
AU2013246443B2
(en)
|
2012-04-11 |
2017-04-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric antigen receptors targeting B-cell maturation antigen
|
|
UY35091A
(es)
|
2012-10-24 |
2014-05-30 |
Onyx Therapeutics Inc |
Formulaciones de liberacion modificada para oprozomib
|
|
EP2914628A1
(en)
|
2012-11-01 |
2015-09-09 |
Max-Delbrück-Centrum für Molekulare Medizin |
An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
|
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Bcma抗原結合蛋白質
|
|
US9243058B2
(en)
|
2012-12-07 |
2016-01-26 |
Amgen, Inc. |
BCMA antigen binding proteins
|
|
JP6636803B2
(ja)
|
2013-02-05 |
2020-01-29 |
エンクマフ エスアーエールエル |
Bcmaに対する抗体の選択のための方法
|
|
AR095374A1
(es)
|
2013-03-15 |
2015-10-14 |
Amgen Res Munich Gmbh |
Moléculas de unión para bcma y cd3
|
|
GB201317928D0
(en)
|
2013-10-10 |
2013-11-27 |
Ucl Business Plc |
Molecule
|
|
EP3131927B8
(en)
|
2014-04-14 |
2020-12-23 |
Cellectis |
Bcma (cd269) specific chimeric antigen receptors for cancer immunotherapy
|
|
JP6285274B2
(ja)
|
2014-04-28 |
2018-02-28 |
株式会社ブリヂストン |
バイアスタイヤ及びその製造方法
|
|
GB201409471D0
(en)
*
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
AU2015292744C1
(en)
|
2014-07-21 |
2021-01-21 |
Novartis Ag |
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
|
|
EP3172231B1
(en)
|
2014-07-24 |
2021-05-05 |
Bluebird Bio, Inc. |
Bcma chimeric antigen receptors
|
|
EP2982692A1
(en)
|
2014-08-04 |
2016-02-10 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
|
MA40457A
(fr)
*
|
2014-08-05 |
2017-06-14 |
Exelixis Inc |
Combinaison de médicaments pour traiter le myélome multiple
|
|
EP3023437A1
(en)
|
2014-11-20 |
2016-05-25 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
|
CN113698497A
(zh)
|
2014-12-05 |
2021-11-26 |
纪念斯隆-凯特琳癌症中心 |
靶向b-细胞成熟抗原的嵌合抗原受体及其用途
|
|
HRP20210582T1
(hr)
|
2014-12-05 |
2021-09-03 |
Memorial Sloan Kettering Cancer Center |
Antitijela koja ciljaju antigen sazrijevanja b-stanice i postupci uporabe
|
|
HUE057285T2
(hu)
*
|
2015-04-13 |
2022-04-28 |
Pfizer |
Terápiás ellenanyagok és alkalmazásaik
|
|
CA2992797A1
(en)
*
|
2015-08-03 |
2017-02-09 |
Engmab Sarl |
Monoclonal antibodies against bcma
|
|
EP3147954A1
(en)
|
2015-09-22 |
2017-03-29 |
Nokia Technologies Oy |
Photodetector with conductive channel made from two dimensional material and its manufacturing method
|
|
ES2913208T3
(es)
*
|
2015-12-01 |
2022-06-01 |
Glaxosmithkline Ip Dev Ltd |
Tratamientos de combinación y usos y métodos de los mismos
|